Northwest Biotherapeutics
BETHESDA, Maryland, June 9, 2011 -
- New CEO, COO, CSO and Senior VP Business Development
Northwest Biotherapeutics (OTC.BB: NWBO) today announced that it has made
changes and substantially expanded its management team, adding several highly
experienced executives.
BETHESDA, Maryland, May 26, 2011 -
- Addition of Clinical Sites Ahead of Projections
Northwest Biotherapeutics (OTC.BB: NWBO) today announced that it has
accelerated the addition of clinical trial sites, exceeding its projections
for the doubling of such sites across the U.S.
BETHESDA, Maryland, May 18, 2011 - Northwest Biotherapeutics (OTC Bulletin Board: NWBO) announced today that
it is partnering with Fraunhofer for production of DCVax(R)-L for brain
cancer, for clinical trials and compassionate use cases in Europe.
